GSK to Establish Global Vaccines R&D Centre in the US

News   Apr 09, 2015

 
GSK to Establish Global Vaccines R&D Centre in the US
 
 
 

RELATED ARTICLES

Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

News

Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK. Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments.

READ MORE

Anti-Inflammatory Pill Could Make Vaccines More Effective for the Elderly

News

By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

READ MORE

New Rare Antibody Isolation Strategy

News

A strategy for rapidly isolating rare, naturally occurring antibodies is reported this week. The strategy could aid in developing biological therapeutics and vaccines in the future.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE